CELLINK completes the acquisition of Scienion AG
As announced on August 19, 2020, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire the precision dispensing company Scienion AG. CELLINK has on this day completed the acquisition of all Scienion-shares. The purchase price, on cash- and debt-free basis, amounted to 80 MEUR, of which 40 MEUR was paid in 2,814,032 newly issued shares of series B in CELLINK at a price of 146.6 SEK per share (the “Consideration Shares”) and the reminder in cash. The Consideration Shares are expected to be registered by the Swedish Companies Registration Office during the month of September